Scaled subprofile modeling of resting state imaging data in Parkinson's disease: Methodological issues

Consistent functional brain abnormalities in Parkinson's disease (PD) are difficult to pinpoint because differences from the normal state are often subtle. In this regard, the application of multivariate methods of analysis has been successful but not devoid of misinterpretation and controversy. The Scaled Subprofile Model (SSM), a principal components analysis (PCA)-based spatial covariance method, has yielded critical information regarding the characteristic abnormalities of functional brain organization that underlie PD and other neurodegenerative disorders. However, the relevance of disease-related spatial covariance patterns (metabolic brain networks) and the most effective methods for their derivation has been a subject of debate. We address these issues here and discuss the inherent advantages of proper application as well as the effects of the misapplication of this methodology. We show that ratio pre-normalization using the mean global metabolic rate (GMR) or regional values from a "reference" brain region (e.g. cerebellum) that may be required in univariate analytical approaches is obviated in SSM. We discuss deviations of the methodology that may yield erroneous or confounding factors.

[1]  David Eidelberg,et al.  Metabolic brain networks associated with cognitive function in Parkinson's disease , 2007, NeuroImage.

[2]  T. Ishikawa,et al.  The Metabolic Topography of Parkinsonism , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[3]  Albert Gjedde,et al.  Cortical hypometabolism and hypoperfusion in Parkinson’s disease is extensive: probably even at early disease stages , 2010, Brain Structure and Function.

[4]  David Eidelberg,et al.  Three-fold cross-validation of parkinsonian brain patterns , 2010, 2010 Annual International Conference of the IEEE Engineering in Medicine and Biology.

[5]  Thomas E. Nichols,et al.  Statistical limitations in functional neuroimaging. I. Non-inferential methods and statistical models. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[6]  James Ralph Moeller,et al.  Highly automated computer-aided diagnosis of neurological disorders using functional brain imaging , 2006, SPIE Medical Imaging.

[7]  Anna Barnes,et al.  FDG PET in the differential diagnosis of parkinsonian disorders , 2005, NeuroImage.

[8]  D. Eidelberg Metabolic brain networks in neurodegenerative disorders: a functional imaging approach , 2009, Trends in Neurosciences.

[9]  T. Ishikawa,et al.  Assessment of disease severity in parkinsonism with fluorine-18-fluorodeoxyglucose and PET. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  V. Dhawan,et al.  Changes in network activity with the progression of Parkinson's disease. , 2007, Brain : a journal of neurology.

[11]  Angelo Antonini,et al.  Tc‐99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism , 2002, Movement disorders : official journal of the Movement Disorder Society.

[12]  Chris C. Tang,et al.  Abnormalities in Metabolic Network Activity Precede the Onset of Motor Symptoms in Parkinson's Disease , 2010, The Journal of Neuroscience.

[13]  E. Reiman,et al.  Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias , 2008, Journal of Nuclear Medicine.

[14]  Karl J. Friston,et al.  Statistical parametric maps in functional imaging: A general linear approach , 1994 .

[15]  Koen Van Laere,et al.  Quantification of Parkinson’s disease-related network expression with ECD SPECT , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[16]  D. Alsop,et al.  Parkinson's Disease Spatial Covariance Pattern: Noninvasive Quantification with Perfusion MRI , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[17]  David Eidelberg,et al.  Differential diagnosis of parkinsonian syndromes using PCA-based functional imaging features , 2009, NeuroImage.

[18]  David Eidelberg,et al.  Dissociation of Metabolic and Neurovascular Responses to Levodopa in the Treatment of Parkinson's Disease , 2008, The Journal of Neuroscience.

[19]  J. Kazmierczak,et al.  Analyse logarithmique: deux exemples d'application , 1985 .

[20]  V. Dhawan,et al.  Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease , 2008, Neurology.

[21]  V. Dhawan,et al.  Reproducibility of regional metabolic covariance patterns: comparison of four populations. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[22]  Gianluca Bontempi,et al.  New Routes from Minimal Approximation Error to Principal Components , 2008, Neural Processing Letters.

[23]  J R Moeller,et al.  A Regional Covariance Approach to the Analysis of Functional Patterns in Positron Emission Tomographic Data , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[24]  I. Jolliffe,et al.  ON RELATIONSHIPS BETWEEN UNCENTRED AND COLUMN-CENTRED PRINCIPAL COMPONENT ANALYSIS , 2009 .

[25]  P. Fox,et al.  Computational approaches to network analysis in functional brain imaging , 1994 .

[26]  V. Dhawan,et al.  Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease , 2007, Proceedings of the National Academy of Sciences.

[27]  V. Dhawan,et al.  Network modulation in the treatment of Parkinson's disease. , 2006, Brain : a journal of neurology.

[28]  A. C. Rencher Methods of multivariate analysis , 1995 .

[29]  Yaakov Stern,et al.  Multivariate and univariate neuroimaging biomarkers of Alzheimer's disease , 2008, NeuroImage.

[30]  David Eidelberg,et al.  Metabolic correlates of subthalamic nucleus activity in Parkinson's disease. , 2008, Brain : a journal of neurology.

[31]  Albert Gjedde,et al.  Normalization in PET group comparison studies—The importance of a valid reference region , 2008, NeuroImage.

[32]  Connie M. Borror,et al.  Methods of Multivariate Analysis, 2nd Ed. , 2004 .

[33]  R. Cattell The Scree Test For The Number Of Factors. , 1966, Multivariate behavioral research.

[34]  H. Abdi The Bonferonni and Šidák Corrections for Multiple Comparisons , 2006 .

[35]  James Ralph Moeller,et al.  Abnormal regional brain function in Parkinson's disease: truth or fiction? , 2009, NeuroImage.

[36]  Robert Tibshirani,et al.  The Elements of Statistical Learning: Data Mining, Inference, and Prediction, 2nd Edition , 2001, Springer Series in Statistics.

[37]  Anna Barnes,et al.  Network modulation by the subthalamic nucleus in the treatment of Parkinson's disease , 2006, NeuroImage.

[38]  Chris C. Tang,et al.  Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis , 2010, The Lancet Neurology.

[39]  Albert Gjedde,et al.  Artefactual subcortical hyperperfusion in PET studies normalized to global mean: Lessons from Parkinson’s disease , 2009, NeuroImage.

[40]  G. Alexander,et al.  Application of the scaled subprofile model to functional imaging in neuropsychiatric disorders: A principal component approach to modeling brain function in disease , 1994 .

[41]  David Eidelberg,et al.  The metabolic pathology of dopa‐responsive dystonia , 2005, Annals of neurology.

[42]  J R Moeller,et al.  Divergent expression of regional metabolic topographies in Parkinson's disease and normal ageing. , 1997, Brain : a journal of neurology.

[43]  David Eidelberg,et al.  Network biomarkers for the diagnosis and treatment of movement disorders , 2009, Neurobiology of Disease.

[44]  V. Dhawan,et al.  Abnormal Metabolic Network Activity in Parkinson'S Disease: Test—Retest Reproducibility , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[45]  Carlos A. Berenstein,et al.  Implementation and Application of Principal Component Analysis on Functional Neuroimaging Data , 2001 .

[46]  H. Akaike A new look at the statistical model identification , 1974 .

[47]  Jane S. Paulsen,et al.  Thalamic metabolism and symptom onset in preclinical Huntington's disease. , 2007, Brain : a journal of neurology.

[48]  D. Eidelberg,et al.  Abnormal metabolic networks in atypical parkinsonism , 2008, Movement disorders : official journal of the Movement Disorder Society.

[49]  E. Tolosa,et al.  The diagnosis of Parkinson's disease , 2006, The Lancet Neurology.